AT278 and NovoRapid® in Glucose Clamp Study

NCT04660305 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: AT278
DRUG: NovoRapid

Sponsor

Arecor Limited